{
 "PrintNo":"A6927","Session":2025,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2025-03-18T13:14:47.61656Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Higher Education",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2025-03-18","Committee":"Higher Education"}],
 "Actions":[{"Text":"REFERRED TO HIGHER EDUCATION","Date":"2025-03-18","Chamber":"ASSEMBLY"}],
 "Sponsors":[
  {"ID":1532,"Name":"Tony Simone","Short":"SIMONE"},{"ID":1503,"Name":"Yudelka Tapia","Short":"TAPIA"},
  {"ID":1144,"Name":"Harvey Epstein","Short":"EPSTEIN"},
  {"ID":1468,"Name":"Jessica Gonzalez-Rojas","Short":"GONZALEZ-ROJAS"},
  {"ID":1257,"Name":"Karines Reyes","Short":"REYES"},{"ID":1535,"Name":"MaryJane Shimsky","Short":"SHIMSKY"}
 ],
 "Title":"Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy",
 "Summary":"Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.",
 "LawSection":"Education Law","LawCode":"Amd §§6807 & 6810, Ed L; add §280-d, Pub Health L",
 "ActClause":"AN ACT to amend the education law and the public health law, in relation to prescription labels for mifepristone, misoprostol, gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy for treatment of gender dysphoria",
 "SameAsPrintNo":"S6422-2025"
}